858 studies found for:    "Bacterial Infections" | United States
Show Display Options
Rank Status Study
1 Recruiting Open-Label, Dose-Finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Patients With Suspected or Confirmed Bacterial Infections
Condition: Gram Positive Bacterial Infections
Intervention: Drug: Oritavancin
2 Completed A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children
Conditions: Bacterial Infections;   Pneumonia, Pneumocystis Carinii;   HIV Infections
Interventions: Drug: Azithromycin;   Drug: Atovaquone;   Drug: Sulfamethoxazole-Trimethoprim
3 Completed Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
Condition: Gram Positive Bacterial Infection
Intervention: Drug: Daptomycin
4 Unknown  Early-Onset Sepsis Surveillance Study
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Sepsis;   Gram-Negative Bacterial Infections;   Gram-Positive Bacterial Infections
Intervention:
5 Recruiting Pharmacokinetics and Safety of Solithromycin in Adolescents and Children
Condition: Bacterial Infection
Intervention: Drug: solithromycin
6 Completed Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents
Condition: Bacterial Infections
Intervention: Drug: Solithromycin
7 Completed A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years.
Condition: Bacterial Infections.
Intervention: Drug: Dalbavancin
8 Completed Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections
Condition: Bacterial Infections
Intervention: Drug: Dalbavancin
9 Completed
Has Results
Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections
Condition: Bacterial Infection
Interventions: Drug: ceftaroline;   Drug: linezolid;   Drug: Aztreonam
10 Recruiting Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant
Conditions: Bacterial Infection;   Benign Neoplasm;   Malignant Neoplasm;   Methicillin-Resistant Staphylococcus Aureus Infection;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Untreated Childhood Myeloid Neoplasm
Interventions: Drug: Chlorhexidine Gluconate;   Procedure: Wound Care Management;   Other: Questionnaire Administration;   Other: Laboratory Biomarker Analysis
11 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: ceftaroline;   Drug: vancomycin plus aztreonam;   Drug: Placebo
12 Completed
Has Results
Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections
Condition: Bacterial Infections
Interventions: Drug: IV Vancomycin plus IV Aztreonam;   Drug: Ceftaroline
13 Terminated Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU
Condition: Bacterial Infection
Interventions: Drug: Meropenem;   Drug: Standard antibiotic therapy
14 Recruiting Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Skin Structures and Soft Tissue Infections
Interventions: Drug: delafloxacin;   Drug: vancomycin;   Drug: aztreonam
15 Completed A Study of Safety, Tolerability, and Efficacy of AFN-12520000 in the Treatment of Acute Bacterial Skin and Skin Structure Infections Due to Staphylococci
Conditions: Skin and Subcutaneous Tissue Bacterial Infections;   Wound Infection;   Cutaneous Abscess;   Burn Infection;   Cellulitis
Intervention: Drug: AFN-12520000
16 Completed Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile
Conditions: Bacterial Infections;   Obesity
Intervention: Drug: Clindamycin
17 Completed Bacterial Pulmonary Infection in PICU
Condition: Bacterial Infection
Intervention:
18 Completed New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
Conditions: Pneumonia, Pneumococcal;   Community Acquired Infections;   Gram-positive Bacterial Infections
Intervention: Drug: Antibiotic
19 Terminated Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients
Condition: Gram-Positive Bacterial Infections
Intervention: Drug: Synercid
20 Recruiting Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Conditions: Acute Leukemias of Ambiguous Lineage;   Bacterial Infection;   Diarrhea;   Fungal Infection;   Musculoskeletal Complications;   Neutropenia;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Secondary Acute Myeloid Leukemia;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Intervention: Drug: levofloxacin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years